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and gentamicin, but more susceptible to cefoxitin, minocycline, and
trimethoprim/sulfamethoxazole than the non-O25b-ST131 isolates. Most of
the children were previously healthy with no apparent risk factors.
Conclusions: E. coli O25b-ST131 is a major community-acquired uropatho-
gen in the children population. CTX-M-14 accounts for majority of the
ESBL genotype in O25b-ST131 clones, while non-O25b-ST131 clones are pre-
sent of great diversity in the ESBL resistance mechanism. The O25b-ST131
clone is not associated with more severe clinical disease, but it may make
the diagnosis and selection of antimicrobials for treatment more
challenging.
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Purpose: Traditional methodologies for healthcare-associated infection
(HCAI) surveillance are labor intensive and time consuming which are
ubiquitous application in the healthcare setting. However, infection con-
trol professionals (ICPs) with traditional method rarely monitor whole-
hospital inpatients rather than covering several selected wards. There-
fore, it is absolutely necessary to develop efficient and reliable surveil-
lance method.
Methods: On the basis of clinical data center which has integrated the
data sources of electronic medical record (EMR), clinical chemistry,
microbiology, pharmacy, anesthesia operation, infectious disease report
and discharge diagnoses, we developed an electronic surveillance system
for monitoring HCAI. The system screened out abnormal or positive data
of patient signs (fever and diarrhea), clinical chemistry related to infec-
tion, microbiology results, and labeled inpatients with invasive
procedures.
Results: From 1st May to 31st October, the system screened out 7374
abnormal value in 3078 cases. ICPs followed the cases and identified nosoco-
mial infection cases according to Centers for Disease Control and Preven-
tion’s National Healthcare Safety Network (CDC-NHSN) surveillance
definitions. During this time, 579 cases were identified HCAI in 34342 dis-
charged cases. 873 warning messages were transmitted to short message ser-
vice (SMS), EMR system and Nursing Information System for medical staff.
Nurses implemented interventions on the principle of isolation and gave
feedback by information, and then ICPs traced the intervention effect.
Conclusions: On the basis of clinical data center, we established the elec-
tronic system and achieved great progress in combining surveillance, early
warning, intervention, feedback and tracking information together,. A
closed-loop management of infectious patients in the hospital can be easily
realized owing to the application of this system.
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Purpose: Carbapenem-resistant Acinetobacter baumanni(CR-AB) and Vanco-
mycin-resistant Enterococci (VRE) infections are common and associated
with high mortality and costs. Early identification of asymptomatic carriers
can reduce patient-to-patient transmission. The role of active surveillance
screening is not clear. The study examined whether an active surveillance
screening policy can reduce transmission, and costs associated with CR-AB
and VRE.
Methods: This active surveillance screening policy (ASP) was conducted from
December 2013 to July 2014. All of the newly hospitalized patients with
presence of ventilator/tracheostomy tube, skin wounds, urinary catheteri-
zation, previous admission at nursing home, intensive care unit and respira-
tory care unit and prolong hospitalization for more than 2-4 weeks were
included. Sputum CR-AB and anus VRE culture was performed on day 1 after
admission. A coordinated strategy included environmental cleaning and
disinfection and education and audits with focus on hand hygiene and con-
tact isolation was applied. The numbers of health care associated VRE and
CR-AB infection at baseline and after intervention were analyzed by Fisher’s
exact tests.
Results: During the intervention period, the total ASP prevalence rate at
admission for CR-AB was 4.7% (12/255) and those patients who transferred
from other hospital yielded the higher prevalence rate 10%, followed by pa-
tients from nursing home (5.4%). The ASP prevalence rate for VRE was 9.2%
(22/238) and those patients who transferred from other hospitals had the
higher prevalence rate of 14.6%. There was 34 CR-AB and VRE colonization
detected during this period. The cost increased US$603 per month after
implementation of ASP. However, no any new health care associated infec-
tions were found during this intervention period.
Conclusions: If the potential outbreak prevention effect in the 34 CR-AB and
VRE colonizer were taken into account, this ASP intervention would be cost
saving (US$12,627 v.s US$4,821) and no any health care associated infections
occurred.
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Purpose: Serratia marcescens is a species of rod-shaped Gram-negative bac-
teria, which is abundant in presence in the environment and involved in hos-
pital-acquired infections (HAIs), particularly catheter-associated
bacteremia, urinary tract infections and wound infections and is responsible
for 1.4% of HAI cases in the United States.
Infection control practitioners detected two nosocomial bloodstream infec-
tion cases in succession in a neurosurgical ward. Both patients developed
typical bacteremia signs and symptoms such as fever, chills and tachycardia
when injected with the Mannitol drug.
Methods: Site investigations found an inappropriate heating process
instantly.
Though the original Mannitol packing had been contaminated in the
beginning, but subsequently, the laboratory confirmed the fluid in the
original Mannitol bottle was sterile. Meanwhile the blood specimen and the
intravenous drug within the infusion control set developed the same
bacteria- Serratia marcescen strain. This means health care workers had
contaminated the drug during the preparing or injection process.
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